Simplexa™ COVID-19 Direct assay targets two different regions of the SARS-CoV-2 genome, the ORF1 ab and S gene. This provides high sensitivity and helps prevent false negatives.

  • A simple workflow with minimal hands on time and results in a little more than an hour allows more efficient test reporting and patient management.
  • An easy to use sample to answer system – no extraction and all-in-one reagents.
  • Fast results directly from BAL, nasal swab, nasal wash/aspirate, nasopharyngeal swab and saliva specimens

Simplexa™ COVID-19 Direct is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy Simplexa™ COVID-19 Direct for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring Simplexa™ COVID-19 Direct for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for Simplexa™ COVID-19 Direct or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top